DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20210670

Menorrhagia in a teenager: a rare presentation of paroxysmal nocturnal haemoglobinuria

Salma Sadaf, Pushpalatha Kariyappa

Abstract


Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal disorder characterised by complement mediated hemolysis, thrombosis and bone marrow failure due to mutation of PIG A gene on chromosome X which codes for decoy proteins Glycoprotein anchor (CD55 and CD59) on hematopoietic stem cells. Onset of PNH is typically seen in adulthood. Pediatric cases account for 5-10% of all reported cases. It is largely underdiagnosed in children because of varied presentation and atypical symptoms. Here, we report a young girl who presented with menorrhagia and severe pallor which when evaluated unmasked the underlying PNH with aplastic anemia. She underwent a successful hematopoietic stem cell transplant. She has remained asymptomatic for 2 years highlighting the need for early evaluation and management for a better outcome.


Keywords


PNH, Menorrhagia, Teenager, Pancytopenia, Hemoglobinuria, Nocturnal, Aplastic anemia

Full Text:

PDF

References


Wilmanns J. Paroxysmal nocturnal hemoglobinuria first described in 1882 by paul stubing: An example of cooperation between clinical and basic research. Blut. 1982;45(6):367-73.

Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surrallés J, Castella M et al. Epidemiology of rare anaemias in Europe. Rare Dis Epidemiol. 2010;375-96.

Rahman K, Gupta R, Yadav G, Husein N, Singh M, Nityanand S. Fluorescent Aerolysin (FLAER)-based paroxysmal nocturnal hemoglobinuria (PNH) screening: a single center experience from India. International J Lab Hematol. 2017;39(3):261-71.

Kashyap R, Awasthi N, Gupta R. Clinical and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in Indian patients. J App Hematol. 2018;9(3):85.

Urbano-Ispizua A, Muus P, Schrezenmeier H, Almeida A, Wilson A, Ware R. Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients. Blood. 2015;126(23):3341.

Ware R, Hall S, Rosse W. Paroxysmal nocturnal hemoglobinuria with onset in childhood and adolescence. N Eng J Med. 1991;325(14):991-6.

Socié G, Mary J, de Gramont A, Rio B, Leporrier M, Rose C et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. The Lancet. 1996;348(9027):573-7.

Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106: 3699-709.

Rotoli B, Luzzatto L. Paroxysmal nocturnal haemoglobinuria. Baillière's Clinl Haematol. 1989;2(1):113-8.

Schrezenmeier H, Muus P, Socie G, Szer J, Urbano-Ispizua A, Maciejewski J et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica. 2014;99(5):922-9.

De Latour R, Mary J, Salanoubat C, Terriou L, Etienne G, Mohty M et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112(8):3099-106.

Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102(10):3587-91.